Teva Pharmaceutical Industries Ltd. | Balance Sheet
Fiscal year is January-December. All values ILS Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,707
9,320
27,070
6,454
3,451
6,726
Total Accounts Receivable
18,528
21,045
20,817
28,953
24,746
21,755
Inventories
17,539
17,010
15,432
19,066
17,094
17,679
Other Current Assets
7,848
8,647
8,268
11,831
8,110
5,385
Total Current Assets
47,622
56,021
71,588
66,305
53,401
51,545
Net Property, Plant & Equipment
23,030
25,431
25,463
31,070
26,638
25,664
Total Investments and Advances
3,783
708
5,938
1,428
375
217
Intangible Assets
88,361
93,083
103,891
253,611
159,883
145,442
Other Assets
-
3,888
3,268
3,325
2,861
2,515
Total Assets
164,900
180,641
211,121
358,144
245,151
226,757
ST Debt & Current Portion LT Debt
6,262
6,853
6,167
12,608
12,658
Accounts Payable
11,513
12,340
13,984
8,302
7,183
Income Tax Payable
128
132
121
-
-
Other Current Liabilities
23,627
28,497
30,331
50,244
42,375
Total Current Liabilities
41,531
47,822
50,603
71,154
62,215
Long-Term Debt
36,053
33,334
32,619
125,173
100,084
Provision for Risks & Charges
975
1,300
-
-
-
Deferred Taxes
2,225
2,775
5,829
18,427
9,384
Other Liabilities
3,443
3,016
4,650
6,308
6,398
Total Liabilities
86,331
89,756
94,673
223,468
180,074
Common Equity (Total)
78,323
90,721
103,027
114,370
47,659
Total Shareholders' Equity
78,323
90,721
115,833
128,302
60,264
Total Equity
78,570
90,885
116,447
134,676
65,076
Liabilities & Shareholders' Equity
164,900
180,641
211,121
358,144
245,151
Accumulated Minority Interest
246
163
615
6,373
4,812
Preferred Stock (Carrying Value)
-
-
12,805
13,932
12,606
About Teva Pharmaceutical Industries
View Profile
